Initial Statement of Beneficial Ownership (3)
August 08 2017 - 6:08PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Wilson George Laverne
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
8/1/2017
|
3. Issuer Name
and
Ticker or Trading Symbol
Quanex Building Products CORP [NX]
|
(Last)
(First)
(Middle)
1800 W. LOOP SOUTH, SUITE 1500
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
_____ 10% Owner
___
X
___ Officer (give title below)
_____ Other (specify below)
Chief Operating Officer /
|
(Street)
HOUSTON, TX 77027
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Common Stock
|
26608
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Stock Options (Right to Buy)
|
(1)
|
4/1/2021
|
Common Stock
|
15000
|
$20.27
|
D
|
|
Stock Options (Right to Buy)
|
(2)
|
11/30/2021
|
Common Stock
|
17600
|
$15.08
|
D
|
|
Stock Options (Right to Buy)
|
(3)
|
12/5/2022
|
Common Stock
|
14900
|
$21.11
|
D
|
|
Stock Options (Right to Buy)
|
(4)
|
12/5/2023
|
Common Stock
|
7300
|
$17.63
|
D
|
|
Stock Options (Right to Buy)
|
(5)
|
12/3/2024
|
Common Stock
|
6300
|
$20.28
|
D
|
|
Stock Options (Right to Buy)
|
(6)
|
12/2/2025
|
Common Stock
|
14400
|
$19.31
|
D
|
|
Stock Options (Right to Buy)
|
(7)
|
11/30/2026
|
Common Stock
|
17100
|
$19.45
|
D
|
|
Explanation of Responses:
|
(1)
|
The options became exercisable in three equal annual installments. The first installment became exercisable on April 1, 2012, and the next two installments became exercisable on April 1, 2013 and April 1, 2014.
|
(2)
|
The options became exercisable in three equal annual installments. The first installment became exercisable on November 30, 2012, and the next two installments became exercisable on November 30, 2013 and November 30, 2014.
|
(3)
|
The options became exercisable in three equal annual installments. The first installment became exercisable on December 5, 2013, and the next two installments became exercisable on December 5, 2014, and December 5, 2015.
|
(4)
|
The options became exercisable in three equal annual installments. The first installment became exercisable on December 5, 2014, and the next two installments became exercisable on December 5, 2015, and December 5, 2016.
|
(5)
|
The options will become exercisable in three equal annual installments. The first installment became exercisable on December 3, 2015, the second installment became exercisable on December 3, 2016, and the third installment becomes exercisable on December 3, 2017.
|
(6)
|
The options will become exercisable in three equal annual installments. The first installment became exercisable on December 2, 2016, and the next two installments become exercisable on December 2, 2017, and December 2, 2018.
|
(7)
|
The options will become exercisable in three equal annual installments. The first installment becomes exercisable on November 30, 2017, and the next two installments become exercisable on November 30, 2018 and November 30, 2019.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Wilson George Laverne
1800 W. LOOP SOUTH
SUITE 1500
HOUSTON, TX 77027
|
|
|
Chief Operating Officer
|
|
Signatures
|
/s/ Paul B. Cornett, Power of Attorney
|
|
8/8/2017
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Quanex (NYSE:NX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Quanex (NYSE:NX)
Historical Stock Chart
From Apr 2023 to Apr 2024